ArticleFrontiers in immunology2024

Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation.

Oana Hangiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.